Beatriz Barquiel1, Lucrecia Herranz2, Diego Meneses2, Óscar Moreno2, Natalia Hillman2, Mª Ángeles Burgos3, José Luis Bartha3. 1. Diabetes and Pregnancy Unit, Division of Diabetes, La Paz University Hospital, Paseo de la Castellana 261, CP 28046, Madrid, Spain. beatriz.barquiel@gmail.com. 2. Diabetes and Pregnancy Unit, Division of Diabetes, La Paz University Hospital, Paseo de la Castellana 261, CP 28046, Madrid, Spain. 3. Diabetes and Pregnancy Unit, Department of Obstetrics, La Paz University Hospital, Madrid, Spain.
Abstract
OBJECTIVES: Our aim was to investigate the greatest gestational weight gain (GWG) without adverse pregnancy complications in women with gestational diabetes mellitus (GDM) and morbid obesity. METHODS: An observational retrospective study including 3284 patients with single pregnancies and GDM was completed. Of the patients, 131 (4.0%) were classified as having pre-pregnancy morbid obesity (BMI ≥ 35 kg/m2). Perinatal complications were compared among BMI groups. In the group with morbid obesity, GWG threshold values to predict outcomes were examined based on sensitivity and specificity values under the receiver operating characteristic curve. RESULTS: GWG was higher in mothers with morbid obesity and macrosomic neonates: 11.3 (4.4-15.7) versus 4.8 (1.5-8.2) kg (p = 0.033). The GWG and neonatal ponderal index were positively correlated (r = 0.305, p = 0.001). The GWG was 7.0 (2.9-11.6) kg in women with hypertensive disorder versus 4.5 (1.0-7.5) kg in normotensive women (p = 0.017). A GWG above 5 kg was a risk factor for macrosomia (87.8% sensitivity, 54.7% specificity) and hypertensive disorder (70.0% sensitivity, 48.4% specificity). GWG associations were maintained after controlling for glycemic control, maternal and gestational age, parity, smoking and neonatal sex. CONCLUSIONS FOR PRACTICE: A GWG below 5 kg is recommended for women with GDM and morbid obesity. In these women, adequate GWG may prevent macrosomia, fetal overgrowth and hypertensive disorder.
OBJECTIVES: Our aim was to investigate the greatest gestational weight gain (GWG) without adverse pregnancy complications in women with gestational diabetes mellitus (GDM) and morbid obesity. METHODS: An observational retrospective study including 3284 patients with single pregnancies and GDM was completed. Of the patients, 131 (4.0%) were classified as having pre-pregnancy morbid obesity (BMI ≥ 35 kg/m2). Perinatal complications were compared among BMI groups. In the group with morbid obesity, GWG threshold values to predict outcomes were examined based on sensitivity and specificity values under the receiver operating characteristic curve. RESULTS: GWG was higher in mothers with morbid obesity and macrosomic neonates: 11.3 (4.4-15.7) versus 4.8 (1.5-8.2) kg (p = 0.033). The GWG and neonatal ponderal index were positively correlated (r = 0.305, p = 0.001). The GWG was 7.0 (2.9-11.6) kg in women with hypertensive disorder versus 4.5 (1.0-7.5) kg in normotensive women (p = 0.017). A GWG above 5 kg was a risk factor for macrosomia (87.8% sensitivity, 54.7% specificity) and hypertensive disorder (70.0% sensitivity, 48.4% specificity). GWG associations were maintained after controlling for glycemic control, maternal and gestational age, parity, smoking and neonatal sex. CONCLUSIONS FOR PRACTICE: A GWG below 5 kg is recommended for women with GDM and morbid obesity. In these women, adequate GWG may prevent macrosomia, fetal overgrowth and hypertensive disorder.
Authors: Javier Aranceta; Carmen Pérez Rodrigo; Lluís Serra Majem; Lourdes Ribas Barba; Joan Quiles Izquierdo; Jesús Vioque; Josep Tur Marí; José Mataix Verdú; Juan Llopis González; Rafael Tojo; Màrius Foz Sala Journal: Med Clin (Barc) Date: 2003-05-03 Impact factor: 1.725
Authors: I-M Claesson; G Sydsjö; J Brynhildsen; M Cedergren; A Jeppsson; F Nyström; A Sydsjö; A Josefsson Journal: BJOG Date: 2007-10-25 Impact factor: 6.531
Authors: Xinglei Xie; Jiaming Liu; Isabel Pujol; Alicia López; María José Martínez; Apolonia García-Patterson; Juan M Adelantado; Gemma Ginovart; Rosa Corcoy Journal: J Clin Med Date: 2020-10-18 Impact factor: 4.964